Kanzaki, Japan

Terumi Hachiya

This inventor holds 6 USPTO granted patents. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 1977-1995.


% Patents Active = 100.0

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Chiyoda, JA (1977)
  • Chiyoda, JP (1980)
  • Chiyodamachi, JP (1983)
  • Kanzaki, JP (1992 - 1994)
  • Tosu, JP (1995)

Company Filing History:


Years Active: 1977-1995

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Terumi Hachiya: Innovator in Pharmaceutical Chemistry

Introduction

Terumi Hachiya is a renowned inventor hailing from Kanzaki, Japan. With a significant portfolio of six patents, she has made notable contributions to the field of pharmaceutical chemistry, particularly in the synthesis of innovative chemical compounds.

Latest Patents

Among her latest inventions are patents focused on phenylalkanoic acid derivatives. One such patent outlines a novel phenylalkanoic acid derivative represented by a specific formula, where n can range from 1 to 2, and X can be a halogen atom, an alkoxyl group, or a nitro group. Additionally, her work also includes the process for producing azacycloalkane derivatives, contributing to advancements in medicinal chemistry.

Career Highlights

Terumi Hachiya is associated with Hisamitsu Pharmaceutical Company, Inc., where she continues to innovate and develop pharmaceutical solutions. Her work is essential in formulating new drugs that could improve therapeutic outcomes for various health conditions.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Kanji Noda and Akira Nakagawa. Their combined expertise has fostered an environment of innovation and discovery within their research endeavors.

Conclusion

Terumi Hachiya's contributions to the pharmaceutical industry underscore the importance of innovation and collaboration in advancing healthcare solutions. With her continued work and impressive patent portfolio, she remains a key figure in the development of new medicinal compounds.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…